CTRI/2018/01/011356已完成未知
Study of trough plasma imatinib levels and its correlation with early responses in Chronic Myeloid leukemia in chronic phase.
Tata Memorial Hospital Mumbai0 个研究点目标入组 52 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Chronic Myeloid Leukemia in chronic phase
- •Age more than 18 years
排除标准
- •1. Patients on concurrent medications affecting imatinib drug levels
- •2. Patients who have been priorly treated outside with Imatinib before referral to our institute
- •3. Patients in whom compliance is not assured
- •4. Patients in accelerated phase or blast crisis of chronic myeloid leukemia as per the WHO definition
研究者
相似试验
已完成
不适用
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid LeukemiaChronic Myeloid LeukemiaNCT00947830Brian Leber81
进行中（未招募）
不适用
Does imatinib therapy lead to an increased uptake of low molecular weight substances into solid tumor metastasis in patients with hormone refractory prostate cancer? - PET_ONKOpatients with HRPC and bone metastases will be enrolled in the studyEUCTR2006-001539-23-ATdepartment of clinical pharmacology10
已完成
2 期
A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and RifabutinTuberculosisNCT03891901National Institute of Allergy and Infectious Diseases (NIAID)24
已完成
4 期
Population Pharmacokinetics study of ImatinibChronic myeloid leukaemia (CML).Chronic myeloid leukaemia [CML], BCR/ABL-positiveIRCT2014050612206N1Kerman University of Medical Sciences220
已完成
1 期
Phase I study of imatinib and LBH589 in imatinib- and sunitinib-refractory gastrointestinal stromal tumorsMedDRA - 10051066 Gastrointestinal stromal tumorDRKS00000657niversitätsklinikum Essen12